Key facts
- Notable investors include Changchun Huize Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Xiehe Lingkang
- ·The full record, as it builds
Funding rounds
No funding rounds for Xiehe Lingkang are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xiehe Lingkang
Manufacturer of health care products and biotechnology research intended to advance biological innovation and enhance human well-being. The company offers proprietary bio-formulation development, functional health products, and scientific testing capabilities, enabling healthcare enterprises and wellness consumers to improve health outcomes and reliable clinical effectiveness.
- Sector
- Healthcare
- HQ
- Changchun, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Xiehe Lingkang doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xiehe Lingkang shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xiehe Lingkang in its N-PORT filings yet. We sweep new filings monthly.